Ginkgo Bioworks Holdings (DNA) Change in Cash (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Change in Cash of -$23.7 million for Q1 2026, down 142.77% on a QoQ basis from $55.4 million in Q4 2025, and up 90.53% year-over-year from -$12.4 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Change in Cash (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Change in Cash history runs 7 years deep, the most recent figure standing at -$23.7 million for Q1 2026.
- Quarterly Change in Cash rose 90.53% year-over-year to -$23.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$166.7 million (up 68.65% YoY) and the FY2025 annual result came in at -$393.4 million, down 2.48% from the prior year.
- Change in Cash was -$23.7 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $55.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $55.4 million in Q4 2025 and bottomed at -$250.3 million in Q1 2025.
- A 5-year average of -$82.6 million and a median of -$94.4 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash sank 536.35% — and 2025, when it surged 199.31%.
- Ginkgo Bioworks Holdings' Change in Cash stood at $24.1 million in 2022, then sank by 536.35% to -$105.0 million in 2023, then jumped by 46.88% to -$55.8 million in 2024, then jumped by 199.31% to $55.4 million in 2025, then sank by 142.77% to -$23.7 million in 2026.
- Business Quant data shows DNA's Change in Cash at -$23.7 million in Q1 2026, $55.4 million in Q4 2025, and -$94.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -23.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.70 Mn |
| Dec 31, 2025 | 55.41 Mn |
| Sep 30, 2025 | -94.39 Mn |
| Jun 30, 2025 | -104.05 Mn |
| Mar 31, 2025 | -250.34 Mn |
| Dec 31, 2024 | -55.80 Mn |
| Sep 30, 2024 | -114.20 Mn |
| Jun 30, 2024 | -111.47 Mn |
| Mar 31, 2024 | -102.37 Mn |
| Dec 31, 2023 | -105.04 Mn |
| Sep 30, 2023 | -77.44 Mn |
| Jun 30, 2023 | -86.61 Mn |
| Mar 31, 2023 | -110.91 Mn |
| Dec 31, 2022 | 24.07 Mn |
| Sep 30, 2022 | -75.33 Mn |
| Jun 30, 2022 | -115.01 Mn |
| Mar 31, 2022 | -57.08 Mn |
| Dec 31, 2021 | -172.37 Mn |
| Sep 30, 2021 | 1.51 Bn |
| Jun 30, 2021 | -60.97 Mn |